Life Healthcare Group Holdings Limited (LTGHY) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
P/E 2.53 means the share price is 2.53 times one year of earnings per share; the S&P 500 usually sits near 20-25. Market cap $1.05B is the value of all shares combined. Beta 0.08: the stock has moved about 92% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerLife Healthcare Group Holdings Limited (LTGHY) trades at $2.94. Life Healthcare Group Holdings Limited operates private hospitals and complementary services across South Africa, Canada, the United Kingdom, and Europe. Market cap: $1.05B, Sector: Healthcare.
Price as of Sep 11, 2026 · Last analyzed: Mar 18, 2026Analyst Coverage for LTGHY: LTGHY does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates LTGHY against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
LTGHY: 2/2 scored disciplines lean bullish. Dominant signal: Seth Klarman bullish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Life Healthcare Group Holdings Limited (LTGHY) Healthcare & Pipeline Overview
Life Healthcare Group Holdings Limited is a global healthcare provider specializing in private hospitals and complementary services, with a significant presence in South Africa and expanding operations in international markets. The company boasts a diverse service portfolio, including acute care, mental health, and diagnostics, reflected in a 15.3% profit margin.
What Is the Investment Thesis for LTGHY?
Life Healthcare presents a compelling, albeit high-yield, investment case based on its established market presence and diverse service offerings. Growth catalysts include expansion of its specialized services and strategic acquisitions in international markets. However, investors should carefully consider the risks associated with currency fluctuations and regulatory changes in the healthcare sector. The company's beta of 0.08 indicates low volatility compared to the market, which may appeal to risk-averse investors seeking stable returns. Continued focus on operational efficiency and strategic partnerships will be crucial for sustaining growth and maximizing shareholder value.
Based on FMP financials and quantitative analysis
LTGHY Key Highlights
Market capitalization of $1.05B, reflecting its significant presence in the healthcare sector.
- P/E ratio of 2.53, suggesting potential undervaluation compared to industry peers.
- Profit margin of 15.3%, indicating efficient operations and profitability.
- Gross margin of 25.6%, demonstrating the company's ability to manage costs effectively.
- Dividend yield of 26.03%, offering a substantial return to investors.
Who Are LTGHY's Competitors?
LTGHY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| ARRJF Arjo AB (publ) | $2.87 | -1.55% | $780M | — |
| EXETF Extendicare Inc. | $22.20 | -0.05% | $2.11B | — |
| GNMLF Genomma Lab Internacional, S.A.B. de C.V. | $0.78 | 0.00% | $761M | 529-signal |
| NWKHY Netcare Limited | $11.45 | 0.00% | $1.35B | — |
| PHCI Panamera Holdings Corporation | $2.50 | 0.00% | $185M | — |
| USPH U.S. Physical Therapy, Inc. | $77.37 | -0.64% | $1.18B | 605-pillar |
| AMN AMN Healthcare Services, Inc. | $33.05 | -3.81% | $1.28B | 935-pillar |
| PNTG The Pennant Group, Inc. | $39.07 | -1.33% | $1.36B | 695-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are LTGHY's Key Strengths?
Diversified service offerings across acute care, mental health, and diagnostics.
- Established presence in South Africa and international markets.
- Integrated healthcare solutions, including employee health programs.
- Strong financial performance with a 15.3% profit margin.
What Are LTGHY's Weaknesses?
Exposure to currency fluctuations in international markets.
- Dependence on medical aid schemes and private insurance.
- Potential regulatory challenges in the healthcare sector.
- Limited brand recognition in some international markets.
What Could Drive LTGHY Stock Higher?
LTGHY catalyst: Expansion of specialized services, such as oncology and cardiology, to meet the growing demand for these treatments.
- Potential strategic acquisitions in international markets to expand geographic footprint within the next 2-3 years.
- Development of telehealth services to improve access to healthcare and reduce costs.
- Expansion of employee wellness programs to help employers reduce healthcare costs and improve employee productivity.
What Are the Key Risks for LTGHY?
Exposure to currency fluctuations in international markets.
- Changes in healthcare regulations and reimbursement policies.
- Economic downturns affecting healthcare spending.
- Increasing competition from other private hospital groups.
- Dependence on medical aid schemes and private insurance.
What Are the Growth Opportunities for LTGHY?
- Expansion of Specialized Services: Life Healthcare can expand its specialized services, such as oncology and cardiology, to meet the growing demand for these treatments. The global oncology market is projected to reach $286.6 billion by 2030, presenting a significant opportunity for Life Healthcare to increase its revenue and market share. Timeline: Ongoing expansion with targeted investments in new technologies and facilities.
- Strategic Acquisitions in International Markets: Life Healthcare can pursue strategic acquisitions in international markets to expand its geographic footprint and diversify its revenue streams. Emerging markets in Asia and Africa offer significant growth potential due to increasing healthcare spending and unmet medical needs. Timeline: Potential acquisitions within the next 2-3 years, subject to regulatory approvals and market conditions.
- Development of Telehealth Services: Life Healthcare can develop telehealth services to improve access to healthcare and reduce costs. The telehealth market is expected to grow rapidly in the coming years, driven by technological advancements and increasing demand for remote healthcare services. Timeline: Gradual implementation of telehealth services over the next 1-2 years.
- Focus on Employee Wellness Programs: Life Healthcare can expand its employee wellness programs to help employers reduce healthcare costs and improve employee productivity. The corporate wellness market is growing rapidly, driven by increasing awareness of the benefits of wellness programs. Timeline: Expansion of employee wellness programs over the next 1-2 years.
- Investment in Diagnostic Imaging Technologies: Life Healthcare can invest in advanced diagnostic imaging technologies, such as PET-CT scanners, to improve the accuracy and efficiency of diagnoses. The diagnostic imaging market is growing rapidly, driven by technological advancements and increasing demand for early disease detection. Timeline: Ongoing investment in diagnostic imaging technologies to enhance service offerings.
What Are LTGHY's Competitive Advantages?
- Established network of private hospitals and complementary services.
- Strong reputation for quality care and specialized treatments.
- Integrated healthcare service offerings, including diagnostics and employee health solutions.
- Geographic diversification across South Africa, Canada, the United Kingdom, and Europe.
What Does LTGHY Do?
Life Healthcare Group Holdings Limited, originally founded as Afrox Healthcare Limited in 1983 and rebranded in 2005, has grown into a multinational healthcare organization. Headquartered in Johannesburg, South Africa, the company operates a network of private hospitals and complementary services across South Africa, Canada, the United Kingdom, and the rest of Europe. Life Healthcare operates through two primary segments: Hospitals and Complementary Services, and Healthcare Services. The Hospitals and Complementary Services segment provides a range of acute hospital care, including specialized services like diagnostics, mental health, acute rehabilitation, renal dialysis, oncology, cardiology, neurology, orthopedics, pediatrics, dermatology, ophthalmology, gynecology, and obstetrics. Additionally, it offers Life Esidimeni services, encompassing chronic mental healthcare, frail care rehabilitation, step-down care, correctional services, primary healthcare, and substance abuse recovery programs. The Healthcare Services segment focuses on life employee health solutions, providing on-site occupational and primary healthcare services, as well as employee wellness programs. The company also develops, manufactures, and distributes radiopharmaceuticals for use in positron emission tomography-computerized tomography (PET-CT) diagnostics, enhancing its integrated healthcare service offerings.
What Products and Services Does LTGHY Offer?
- Operates private hospitals in South Africa, Canada, the United Kingdom, and Europe.
- Provides acute hospital care services, including specialized treatments.
- Offers Life Esidimeni services, such as mental healthcare and rehabilitation.
- Provides employee health solutions, including on-site occupational and primary healthcare.
- Offers diagnostic imaging services, including MRI and CT scans.
- Develops, manufactures, and distributes radiopharmaceuticals for PET-CT diagnostics.
How Does LTGHY Make Money?
- Generates revenue from hospital services, including inpatient and outpatient care.
- Earns revenue from complementary services, such as mental healthcare and rehabilitation.
- Receives payments from medical aid schemes, private insurance, and self-paying patients.
- Derives income from employee health solutions provided to corporate clients.
What Industry Does LTGHY Operate In?
Life Healthcare operates within the global healthcare industry, which is experiencing growth driven by aging populations, increasing prevalence of chronic diseases, and technological advancements. The private hospital sector is competitive, with key players focusing on service differentiation and geographic expansion. Life Healthcare's presence in South Africa and international markets positions it to capitalize on these trends. Competitors include ARRJF (Ascendis Health), EXETF (Excellence et Technologies), GNMLF (Genus Lifesciences Inc), NWKHY (Newmark Healthcare Holdings, Inc.), and PHCI (Premier Healthcare Corp). The company's focus on specialized services and employee health solutions differentiates it within the competitive landscape.
Who Are LTGHY's Key Customers?
- Patients seeking acute hospital care and specialized treatments.
- Individuals requiring mental healthcare and rehabilitation services.
- Corporations seeking employee health solutions and wellness programs.
- Medical aid schemes and private insurance companies.
- Healthcare providers utilizing diagnostic imaging services and radiopharmaceuticals.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● Latest filing 164 days ago
- ● No analyst coverage
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 42 |
| 2026-08-26 | 42 |
| 2026-08-29 | 42 |
| 2026-09-01 | 42 |
| 2026-09-04 | 42 |
| 2026-09-07 | 42 |
| 2026-09-10 | 42 |
What changed?
The score has stayed at 42.
Over the same 18 days the stock moved +4.5%.
Company Profile
Life Healthcare Group Holdings Limited operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Johannesburg, ZA. The company is led by CEO Peter Gerard Wharton-Hood Harvard. LTGHY has traded publicly since 2013.
Key Financial Metrics
Return on equity for Life Healthcare Group Holdings Limited stands at 60.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 29.3%, showing how much profit it generates from its asset base. LTGHY trades at a trailing price-to-earnings ratio of 2.53, below the Healthcare sector average of ~21.50x. Its free cash flow yield is 12.7%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.45 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 45.8%, the inverse of the P/E and a quick read on earnings relative to price.
LTGHY Valuation & Market Position
With a $1.05B market cap, Life Healthcare Group Holdings Limited sits in the small-cap segment of the market.
Quarterly Financial Performance: Life Healthcare Group Holdings Limited
Revenue for Life Healthcare Group Holdings Limited came in at $12.59B during Q2 FY2026, a 1.8% contraction versus the preceding quarter. The company recorded net income of $781.6M, with diluted EPS of $2.20. Quarter-over-quarter revenue has been mixed, typical for a small-cap company operating in Healthcare. Across the four most recent quarters, LTGHY averaged $3.97 in diluted EPS.
Financial Health
Life Healthcare Group Holdings Limited's Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 3.52 places it in the safe zone, indicating low near-term bankruptcy risk.
LTGHY Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Diversified service offerings across acute care, mental health, and diagnostics.
- Established presence in South Africa and international markets.
- Integrated healthcare solutions, including employee health programs.
- Strong financial performance with a 15.3% profit margin.
Bear Case
- Exposure to currency fluctuations in international markets.
- Dependence on medical aid schemes and private insurance.
- Potential regulatory challenges in the healthcare sector.
- Limited brand recognition in some international markets.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 FY2026 | R12.59B | R782M | R2.20 |
| Q4 FY2025 | R12.82B | R6.08B | R16.12 |
| Q2 FY2025 | R12.28B | -R2.22B | -R6.04 |
| Q4 FY2024 | R13.93B | R1.33B | R3.60 |
Q2 FY2026 · filed 31 Mar 2026 · SEC EDGAR →
Based on FMP financials and quantitative analysis · Reported in ZAR
LTGHY Latest News
-
Stocks That Hit 52-Week Lows On Thursday
· Aug 15, 2019
-
Stocks That Hit 52-Week Lows On Wednesday
· Aug 14, 2019
-
Stocks That Hit 52-Week Lows Of Tuesday
· Aug 13, 2019
-
Stocks That Hit 52-Week Lows Of Monday
· Aug 12, 2019
LTGHY Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for LTGHY.
Price Targets
Wall Street price target analysis for LTGHY.
LTGHY MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for LTGHY; grades run from A+ (80-100) to F (below 30).
Leadership: Peter Gerard Wharton-Hood Harvard
CEO
Peter Gerard Wharton-Hood is the Chief Executive Officer of Life Healthcare Group Holdings Limited. His background includes extensive experience in the healthcare industry, with a focus on strategic leadership and operational management. He has a strong academic foundation, having attended Harvard University, which has equipped him with the skills necessary to lead a complex organization like Life Healthcare. His previous roles have included leadership positions in various healthcare organizations, where he has demonstrated a track record of driving growth and improving operational efficiency.
Track Record: Under Peter Gerard Wharton-Hood's leadership, Life Healthcare has focused on expanding its specialized services and strengthening its presence in international markets. Key achievements include the successful integration of acquired businesses and the implementation of innovative healthcare solutions. He has also overseen the company's efforts to improve patient care and enhance operational efficiency, contributing to its strong financial performance.
Life Healthcare Group Holdings Limited ADR Information Unsponsored
An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company trading on U.S. stock exchanges. LTGHY is traded as an ADR, allowing U.S. investors to invest in Life Healthcare Group Holdings Limited without directly dealing with foreign stock exchanges. It simplifies the process of owning foreign shares.
- Home Market Ticker: Johannesburg Stock Exchange (JSE), South Africa
- ADR Level: 1
- ADR Ratio: 1:1
- Home Market Ticker: LTGH
LTGHY OTC Market Information
The OTC Other tier represents the lowest tier of the over-the-counter (OTC) market. Companies in this tier often have limited financial disclosure and may not meet the listing requirements of major exchanges like the NYSE or NASDAQ. Trading on the OTC Other tier carries higher risks due to the potential for limited liquidity, less transparency, and greater price volatility. Investors should exercise caution and conduct thorough due diligence before investing in companies on this tier.
- OTC Tier: OTC Other
- Limited financial disclosure and transparency.
- Potential for lower trading volumes and wider bid-ask spreads.
- Greater price volatility compared to stocks listed on major exchanges.
- Higher risk of fraud or manipulation.
- Limited regulatory oversight.
- Verify the company's financial statements and SEC filings (if available).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's growth prospects and potential risks.
- Check for any legal or regulatory issues.
- Review the company's ownership structure and shareholder base.
- Consult with a financial advisor before investing.
- Established presence in South Africa and international markets.
- Operations of private hospitals and healthcare services.
- Audited financial statements (if available).
- Presence of a reputable management team.
- Positive media coverage and industry recognition.
Common Questions About LTGHY (Healthcare)
Is LTGHY a good stock?
Stock Expert AI does not rate LTGHY buy, sell or hold. Life Healthcare Group Holdings Limited has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What do analysts say about LTGHY stock?
Analyst coverage of LTGHY stock is limited due to its OTC listing and ADR Level 1 status. However, key valuation metrics such as the P/E ratio of 2.53 and dividend yield of 26.03% suggest potential undervaluation and attractive income opportunities.
What are the key factors to evaluate for LTGHY?
Evaluate LTGHY on fundamentals, analyst consensus, and risk factors. P/E: 2.53x vs the S&P 500's ~20-25x. Dividend yield of 26.03%, offering a substantial return to investors. Not financial advice.
How frequently does LTGHY data refresh on this page?
LTGHY's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven LTGHY's recent stock price performance?
Life Healthcare Group Holdings Limited (LTGHY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified service offerings across acute care, mental health, and diagnostics. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider LTGHY overvalued or undervalued right now?
Life Healthcare Group Holdings Limited (LTGHY) trades at 2.53x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of LTGHY?
Yes, most major brokerages offer fractional shares of Life Healthcare Group Holdings Limited (LTGHY) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track LTGHY's earnings and financial reports?
Life Healthcare Group Holdings Limited (LTGHY) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for LTGHY earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited analyst coverage due to OTC listing and ADR Level 1 status.
- Financial data based on available sources and may be subject to change.